Cue Biopharma, Inc. — Investor Relations & Filings
Filings indexed
475
across all filing types
Latest filing
2026-04-22
Regulatory Filings
Country
US
United States of America
Listing
US
CUE
Cue Biopharma, Inc. is a clinical-stage biopharmaceutical company developing a novel class of injectable, engineered biologics to selectively modulate the human immune system. The company's proprietary platform creates therapeutics designed to mimic natural immune signals to precisely engage, expand, and activate specific, disease-relevant T cells. This targeted approach is being applied to develop immunotherapies for the treatment of cancer and autoimmune diseases, with the goal of restoring immune balance and providing effective treatments for serious conditions.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 8-K - Cue Biopharma, Inc. (0001645460) (Filer) | 2026-04-22 | English | |
| 8-K - Cue Biopharma, Inc. (0001645460) (Filer) | 2026-04-13 | English | |
| 8-K - Cue Biopharma, Inc. (0001645460) (Filer) | 2026-04-07 | English | |
| S-3 - Cue Biopharma, Inc. (0001645460) (Filer) | 2026-03-17 | English | |
| 8-K - CUE BIOPHARMA, INC. (0001645460) (Filer) | 2026-02-18 | English | |
| 8-K Filing | 2026-02-12 | English |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
13 filings
| |||||
| 35251607 | 8-K - Cue Biopharma, Inc. (0001645460) (Filer) | 2026-04-22 | English | ||
| 34434499 | 8-K - Cue Biopharma, Inc. (0001645460) (Filer) | 2026-04-13 | English | ||
| 33706784 | 8-K - Cue Biopharma, Inc. (0001645460) (Filer) | 2026-04-07 | English | ||
| 32965297 | S-3 - Cue Biopharma, Inc. (0001645460) (Filer) | 2026-03-17 | English | ||
| 32895721 | 8-K - CUE BIOPHARMA, INC. (0001645460) (Filer) | 2026-02-18 | English | ||
| 31086230 | 8-K Filing | 2026-02-12 | English | ||
| 12882965 | 4 | 2026-01-06 | English | ||
| 12882966 | 4 | 2026-01-06 | English | ||
| 12882967 | 4 | 2026-01-06 | English | ||
| 12882968 | 4 | 2026-01-06 | English | ||
| 12882969 | 4 | 2026-01-06 | English | ||
| 12882970 | 4 | 2026-01-06 | English | ||
| 12882971 | 4 | 2026-01-02 | English | ||
|
2025
2 filings
| |||||
| 12882972 | Regulatory Filings 2025 | 2025-12-29 | English | ||
| 12882973 | 8-K | 2025-12-19 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
Cue Biopharma, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/34525/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=34525 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=34525 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=34525 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 34525}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Cue Biopharma, Inc. (id: 34525)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.